Mount Vernon, OH, United States of America

Donald Witiak

This inventor holds 1 USPTO granted patent. Top assignee: University of Pittsburgh. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donald Witiak. Retrieved from https://idiyas.com/inventor/donald-witiak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Donald Witiak

Introduction

Donald Witiak is a notable inventor based in Mt. Vernon, Ohio. He has made significant contributions to the field of medicine, particularly in the treatment of sickle cell anemia. His innovative approach has the potential to improve the lives of many individuals affected by this condition.

Latest Patents

Witiak holds a patent for a method of treating sickle cell anemia. This method involves administering a therapeutically effective dosage of a specific compound, where at least one R is Cl, Br, CH₃, or OCH₃, and each other R is H, R' is H, or CH₃, with n being 1, 2, 3, 4, or 5. The preferred compounds include clofibrate, clofibric acid, p-chlorophenoxyacetic acid, and phenoxyacetic acid. This treatment can be administered in solid dosage form and may be used prophylactically to help resist sickle cell crises.

Career Highlights

Witiak is affiliated with the University of Pittsburgh, where he continues to engage in research and development in the medical field. His work has garnered attention for its potential impact on treating sickle cell anemia, a condition that affects many individuals worldwide.

Collaborations

One of Witiak's notable collaborators is Donald J. Abraham. Their partnership has contributed to advancements in medical research and innovation.

Conclusion

Donald Witiak's contributions to the treatment of sickle cell anemia exemplify the importance of innovation in medicine. His work not only highlights his dedication as an inventor but also underscores the potential for new treatments to enhance patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…